The FDA authorized the nation’s first home COVID-19 test without a prescription. The test, made by Australia-based Ellume, will cost about $30.
Author: Ken Alltucker, USA TODAY
‘Momentous event’: HHS Secretary Alex Azar touts COVID-19 vaccine as a key to US herd immunity
Hospitals nationwide began immunizing health care workers Monday after the FDA’s authorization of a COVID-19 vaccine developed by Pfizer and BioNTech.
‘A very, very dark place’: Hospitals brace for crisis-care mode with too many patients, not enough staff
Hospital ICUs are filled with a record number of critically ill Americans with COVID-19, and there’s no relief in sight.
The demand for COVID-19 testing is up across the US, stressing labs and delaying results
Quest Diagnostics and LabCorp said higher COVID-19 testing demand across the U.S. means results will take longer, possibly up to three days.
‘The public has not listened’: Nursing home cases surge to all-time high as COVID-19 sweeps US
Despite federal efforts to shield residents, COVID-19 cases in nursing homes reached an all-time high of 10,279 during the week of Nov. 1.
‘Our neighbors, our family members’: Small-town hospitals overwhelmed by COVID deaths
As COVID deaths surpass 2,000 a day, public health officials say the pandemic is straining rural hospitals short on staffing and expertise.
Hospitals overwhelmed: Exhausted staffs, surging COVID-19 cases push nation’s limits
The worsening COVID-19 outbreak, fueled by Americans’ fatigue, means hospitals are scrambling for more doctors, nurses and therapists to fill shifts.
‘Pushing the frontiers’: Long lines for COVID tests, stressed labs delay results as demand spikes
COVID-19 test results are delayed a week or longer in hotspot communities, undercutting public health efforts to track, isolate and prevent spread.
COVID-19 expert: Coronavirus will rage ‘until it infects everybody it possibly can’
Michael Osterhom, an infectious disease researcher, warns up to 70 percent of people might become infected by COVID-19 unless a vaccine works.
FDA tightens oversight of blood tests used to detect coronavirus antibodies
The FDA is tightening oversight of antibody tests after the agency learned some test makers were making false claims about the blood tests.